stock.name

Protagonist Therapeutics Inc

PTGX

Market Cap$1.6B
Close$

Compare Protagonist Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Protagonist Therapeutics IncProtagonist Therapeutics Inc00%---
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9
$31.15

Current Fair Value

5.5% upside

Undervalued by 5.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.60 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Beta0.64
Outstanding Shares57,678,122
Avg 30 Day Volume877,295

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Protagonist Therapeutics Inc